Obbligazioni GSK
Di seguito è riportato l'elenco delle obbligazioni societarie GSK PLC CEDEAR EACH REPR 1/4 ADR. Gli investitori spesso optano per le obbligazioni di una società per la loro maggiore stabilità in tempi di volatilità del mercato. Studia i prezzi, i rendimenti e altre statistiche per trovare un investimento affidabile.
Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
|---|---|---|---|---|---|---|---|---|---|
| XXS217060907GLAXOSM.CAP. MTN 20/35MTN | 6,24% | 0 | 71,58% | 1,63% | 2035-05-12 | 750 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043 | 6,10% | 312 K | 83,75% | 4,20% | 2043-03-18 | 500 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| 117RIGLAXOSMITHKLINE CAPITAL PLC 4.25% GTD SNR EMTN 18/12/45 | 6,06% | 8,46 K | 82,51% | 4,25% | 2045-12-18 | 370,79 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| 883GIGLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 10/04/2042 | 5,91% | 0 | 94,45% | 5,25% | 2042-04-10 | 477,82 M GBP | 1.000,00 GBP | 50.000,00 GBP | GlaxoSmithKline Capital Plc |
| 771ZCGLAXOSMITHKLINE CAPITAL PLC 6.375% GTD SNR EMTN 09/03/39 | 5,47% | 0 | 107,13% | 6,38% | 2039-03-09 | 631,3 M GBP | 1.000,00 GBP | 50.000,00 GBP | GlaxoSmithKline Capital Plc |
| GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 | 5,35% | 347 K | 107,88% | 6,38% | 2038-05-15 | 2,75 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK6023693GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035 | 5,20% | 2,75 M | 97,86% | 4,88% | 2035-04-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| AAG99GLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 19/12/2033 | 4,78% | 0 | 102,85% | 5,25% | 2033-12-19 | 574,17 M GBP | 1.000,00 GBP | 1.000,00 GBP | GlaxoSmithKline Capital Plc |
| GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027 | 4,70% | 60 K | 100,25% | 4,85% | 2027-03-12 | 600 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| GGSK6023695GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030 | 4,65% | 3,16 M | 99,41% | 4,50% | 2030-04-15 | 850 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| UUS377373AH8GLAXOSM.CAP. 19/29 | 4,65% | 0 | 95,67% | 3,38% | 2029-06-01 | 1 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| 772WIGLAXOSMITHKLINE CAPITAL INC 5.375% GTD SNR NTS 15/04/2034 | 4,57% | 0 | 105,28% | 5,38% | 2034-04-15 | 500 M USD | 1.000,00 USD | 1.000,00 USD | GlaxoSmithKline Capital, Inc. |
| XXS217060184GLAXOSM.CAP. MTN 20/28MTN | 4,38% | 0 | 90,71% | 1,25% | 2028-10-12 | 750 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| UUS377372AN7GLAXOSMITHKLINE CAP.18/28 | 4,27% | 0 | 98,94% | 3,88% | 2028-05-15 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK6023691GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027 | 4,18% | 66 K | 100,22% | 4,32% | 2027-03-12 | 400 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| XXS293369275GSK CAP B.V. 24/36 MTN | 3,78% | 0 | 95,75% | 3,25% | 2036-11-19 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS255381776GSK CAP B.V. 22/32 MTN | 3,34% | 0 | 98,68% | 3,13% | 2032-11-28 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS293369143GSK CAP B.V. 24/31 MTN | 3,16% | 0 | 98,47% | 2,88% | 2031-11-19 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS182282979GLAXOSM.CAP. MTN 18/30MTN | 3,07% | 0 | 94,27% | 1,75% | 2030-05-21 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS168152035GLAXOSM.CAP. MTN 17/29 | 2,79% | 0 | 94,54% | 1,38% | 2029-09-12 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS255381768GSK CAP B.V. 22/27 MTN | 2,49% | 0 | 101,21% | 3,00% | 2027-11-28 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| GGX5CGLAXOSM.CAP. MTN 05/25 | 2,23% | 0 | 100,15% | 4,00% | 2025-06-16 | 750 M EUR | 1.000,00 EUR | 1.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS182282812GLAXOSM.CAP. MTN 18/26MTN | 2,22% | 0 | 99,04% | 1,25% | 2026-05-21 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| GGX5BGLAXOSM.CAP. MTN 17/26 | 2,20% | 0 | 98,46% | 1,00% | 2026-09-12 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| 117RNGLAXOSMITHKLINE CAPITAL PLC 3.375% GTD SNR EMTN 20/12/2027 | 0,84% | 0 | 112,19% | 3,38% | 2027-12-20 | 307,77 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| AAQ72GLAXOSMITHKLINE CAPITAL PLC 0.883% GTD SNR EMTN 21/09/20 | — | — | — | 0,88% | 2028-09-21 | 42,5 B JPY | 100.000.000,00 JPY | 100.000.000,00 JPY | GlaxoSmithKline Capital Plc |